← Back to the page you were readingYou opened this term from another page.

Markush claim

Also called Markush group, Markush grouping, Markush structure, improper Markush grouping, claim reciting alternatives, selected from the group consisting of

Published by Patsnap Team Updated 5 sources
Definition

Markush claim is a patent claim that recites a list of alternatively usable members, for example a material "selected from the group consisting of A, B, and C". The list is called a Markush group or Markush grouping, after the appellant in Ex parte Markush (1924)1.

The USPTO says treatment of claims reciting alternatives is not governed by the format used, and that any claim reciting alternatively usable members, regardless of format, should be treated as a Markush claim1.

Used byInventions in metallurgy, refractories, ceramics, chemistry, pharmacology and biology are most frequently claimed this way, though mechanical features and process steps can be too1
Comes upIn examination: improper Markush grouping rejections and election of species requirements in the US1,2; unity of invention at the EPO4,5
Governed byMPEP 2117, 803.02 and 2173.05(h) (US); EPO Guidelines F-IV, 3.7 and F-V, 3.2.51,2,3,4,5
01

How a Markush group is written

In the US, claim language defined by a Markush grouping requires selection from a closed group "consisting of" the alternative members1. Four practical points follow from the MPEP:

  • A claim that lists alternatives to define a limitation is an acceptable claim construction, and should not necessarily be rejected as confusing under 35 U.S.C. 112(b) or as improper3.
  • If a Markush grouping requires a material selected from an open list, for example a group "comprising" or "consisting essentially of" the alternatives, the claim should generally be rejected under 35 U.S.C. 112(b) as indefinite, because it is unclear what other alternatives are meant to be covered3.
  • If the claim is meant to cover combinations or mixtures of the alternatives, it may say so, for example "at least one member" selected from the group or "or mixtures thereof"3.
  • A long list is not necessarily indefinite, because breadth is not indefiniteness. A group can still be so expansive that persons skilled in the art cannot determine the metes and bounds of the claimed invention3.
02

Proper and improper groupings in the US

A Markush claim may be rejected on "improper Markush grouping" principles if either the members do not share a single structural similarity or they do not share a common use1. The members share a single structural similarity when they belong to the same recognized physical or chemical class or the same art-recognized class, and share a common use when they are disclosed in the specification or known in the art to be functionally equivalent in the context of the claimed invention1.

Where the claim lists alternative chemical compounds that do not belong to a recognized class, the grouping may still be proper if they share a substantial structural feature that is essential to a common use. In In re Harnisch (CCPA 1980), the MPEP says the court found a group of coumarin derivatives proper because the compounds, viewed as wholes, all share a coumarin group and the property of being a dye1.

A rejection for an improper Markush grouping is a rejection on the merits and may be appealed to the Patent Trial and Appeal Board1. To overcome it, an applicant may set out each alternative, or each grouping of patentably indistinct alternatives, in a series of independent or dependent claims, or argue that the members in fact share a single structural similarity and a common use1.

03

Election of species in a Markush claim

A Markush claim may include independent and distinct inventions, in which case the examiner may require the applicant to make a provisional election of a single species, or a grouping of patentably indistinct species, before examination on the merits2. There is one exception: if the members of a proper Markush group are sufficiently few in number or so closely related that the entire claim can be searched and examined without serious burden, the examiner must examine all the members2.

  1. Provisional electionThe applicant's election is the starting point for the search and examination of the claim2.
  2. Examination of the elected speciesThe Markush claim is examined fully for the elected species, and further to the extent needed to determine patentability2.
  3. If the elected species is not allowableIf it is anticipated or rendered obvious, the Markush claim and the claims to the elected species are rejected, and claims to nonelected species are held withdrawn from further consideration2.
  4. If the elected species is allowableExamination of the Markush claim is extended. If prior art then anticipates or renders obvious the claim for a nonelected species, the Markush claim is rejected2.

Where a claim reads on multiple species, only one species needs to be taught or suggested by the prior art for the claim to be anticipated or rendered obvious2. See Prior art for what counts.

04

Markush groups at the USPTO and the EPO

United States

  • A Markush grouping is proper if its members share a single structural similarity and a common use (MPEP 2117)1.
  • A Markush group is a closed group of alternatives (MPEP 2173.05(h))3.
  • Election of species is a type of restriction requirement (MPEP 803.02)2.

Europe

  • A claim, whether independent or dependent, may refer to alternatives if their number and presentation does not make the claim obscure or difficult to construe, and if the claim meets the requirements of unity (Guidelines F-IV, 3.7)4.
  • For a Markush grouping, unity of invention is considered present if the alternatives are of a similar nature and can fairly be substituted for one another (Guidelines F-IV, 3.7)4.
  • For alternatives that are chemical compounds, they are of a similar nature where all have a common property or activity and a common structure is present: either a significant structural element shared by all, or membership of a recognized class of chemical compounds (Guidelines F-V, 3.2.5)5.
  • If at least one Markush alternative is not novel, unity of invention must be reconsidered. Claims covering alternative nucleic acids or proteins defined by different sequences are analyzed under the same principles (Guidelines F-V, 3.2.5)5.
05

Markush treatment compared

United States (USPTO)Europe (EPO)
Where the grouping is testedImproper Markush grouping rejection, and election of species1,2Unity of invention4,5
Test appliedSingle structural similarity and a common use1Alternatives of a similar nature that can fairly be substituted for one another4
Effect of one known alternativeOnly one species needs to be taught or suggested by the prior art for the claim to be anticipated or rendered obvious2Unity of invention must be reconsidered if at least one alternative is not novel5
06

Questions people ask

Patsnap EurekaEureka IP

Draft and prosecute

Patent Drafting AI Agent

An AI agent that drafts claims and a full specification from a disclosure, with a compliance review before you finish.

Start drafting
What does a Markush claim look like?

Typically it names a closed group of alternatives, such as "a material selected from the group consisting of A, B, and C". The USPTO says the format does not decide the treatment: "wherein the material is A, B, or C" is also treated as a Markush claim1.

Can a Markush group be open-ended?

In the US, generally not. A Markush grouping is a closed group of alternatives, and a claim requiring a material selected from an open list, such as a group "comprising" the alternatives, should generally be rejected as indefinite under 35 U.S.C. 112(b)3.

What is an improper Markush grouping?

In US practice, a grouping whose members do not share a single structural similarity or do not share a common use1. It is a merits rejection that can be appealed to the PTAB1.

Does one prior art alternative defeat the whole Markush claim?

In the US, yes: where a claim reads on multiple species, only one species needs to be taught or suggested by the prior art for the claim to be anticipated or rendered obvious2. For the EPO, this page covers only the effect on unity: if at least one Markush alternative is not novel, unity of invention must be reconsidered (Guidelines F-V, 3.2.5)5.

07

How it connects

Builds onPatent claim
Done withOffice action
Next step

Go from the term to the task

Read how the method works, run it on your own product or idea, then try a free tool.

  • 01 / How-toPatentability search: a practical guideCheck whether an invention is new before you spend on a filing.GuideRead
  • 02 / AI agentNovelty Search AI AgentAn AI agent that searches prior art for your invention and compares each reference with it feature by feature.Patsnap EurekaRun it
  • 03 / Free toolPatent draft style studioRewrite a technical description in claim language.AI resultTry tool
PublishedPatsnap Team
Updated 27 October 2026
Sources
  1. MPEP § 2117: Markush Claims. United States Patent and Trademark Office (USPTO). Accessed 21 October 2026.
  2. MPEP § 803.02: Election of Species Requirements - Markush Claims. United States Patent and Trademark Office (USPTO). Accessed 21 October 2026.
  3. MPEP § 2173.05(h): Alternative Limitations. United States Patent and Trademark Office (USPTO). Accessed 21 October 2026.
  4. Guidelines for Examination, Part F, Chapter IV, 3.7: Alternatives in a claim. European Patent Office (EPO). Accessed 21 October 2026.
  5. Guidelines for Examination, Part F, Chapter V, 3.2.5: Markush grouping (alternatives in a single claim). European Patent Office (EPO). Accessed 21 October 2026.
Disclaimer

General information only. This page explains a term for general information and reference only. It is not legal, accounting, tax or other professional advice and must not be relied upon as such. It does not create an attorney-client or other professional relationship.

Sources and accuracy. Statements on this page are intended to be either general background or linked to a source listed under Sources. The explanations summarize and simplify those sources and leave out detail. Where this page differs from a cited source or from the current official text of a law or standard, rely on that source or text. To the extent permitted by law, this page is provided as is, without any warranty that it is complete, accurate or current, and Patsnap accepts no liability for loss arising from reliance on it. See also Patsnap’s website Disclaimer.

Rules vary and change. The law, standards and practice described here differ between jurisdictions and change through legislation, court decisions and revisions to official guidance and standards. This page was last checked against its sources on 27 October 2026 and may not reflect later changes. Check the current rules and official guidance in each jurisdiction that applies to you.

No FTO or validity opinion. Nothing on this page constitutes a freedom-to-operate, novelty, validity or infringement opinion. Any decision touching a live patent dispute should be verified independently and reviewed with qualified patent counsel.

Cases and records as examples. Court decisions, dockets, agency decisions and official reports are cited to show how a term is used, and are summarized rather than reproduced in full. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, that any settlement occurred, or that any party prevailed, beyond what the cited record or decision itself states.

Third-party names, marks and links. Names of courts, government bodies, parties, people, companies, standards and products appear for identification only. Some of these names are trademarks of their owners; their appearance does not, by itself, imply affiliation with or endorsement by Patsnap. Links to third-party sources are provided for reference, and Patsnap is not responsible for their content or availability.

Patsnap Eureka. Patsnap publishes this glossary and also offers Patsnap Eureka, a commercial product mentioned on this page. Those mentions describe what its tools are designed to do, not what they will find in a particular case. Their outputs are research aids and should be reviewed by a qualified professional before being relied on.

Corrections and requests. If you believe a statement on this page is inaccurate or out of date, use “Share feedback” at the bottom of this page and tell us which statement and why. If you are named on this page, or your concern is about legal rights or personal information, email legal@patsnap.com. We review reports and may correct or update the page.

Patent Drafting AI AgentStart drafting in Patsnap EurekaStart →

Help us improve

Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.